| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Mind Your Own Damn Business Sexcess |
|
Just Other Articles - Mind Your Own Damn Business Sexcess
You have certainly heard the expression “mind your own damn business” used in a multitude of contexts. The most typical being t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he don’t kiss and tell type statements, often uttered by responsibly private individuals about their love life. Then there are ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the polar opposite, blabbermouth, tell all people (you know who you are) that just can’t keep their preverbal trap shut. Many lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ay believe that there are specific gender biases towards kissing and telling, yet this remains unproven scientifically. So wha here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t the heck does this have to do with business and let alone success? Consider what happens when you replace “the love life” po d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tion of the kissing and telling story with “your or your employers business”! All of a sudden it hits you. Your success in bus ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ness can be inextricably affected by what comes out of your or your employee’s mouths. Here’s a short, but true, story for you easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi about a salesman that was furious about something while he was out to lunch, at a small caf?. This built up anger was taken o nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t on a waitress, who was one of four high school kids working there for the summer. He was loud, rude, and flat out disrespectf and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ l to the girl, and his overreaction to the situation brought tears to the waitress’s eyes. The three other kids watched and in ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ently listened to the entire incident. One of the two boys behind the counter said, “I know that guy. I’ve seen him in my fath ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a er’s office.” Remarkably, each of the four high school kids had a parent who was a doctor. They found out from the boy’s fathe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod that the angry customer was a salesman for a pharmaceutical company. Then and there, each kid planned to tell their parents n cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t to do business with that salesman. Everybody knows somebody, so remember being nice to someone might not get you a client, b tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ut being mean to someone could kill your business, even if it’s a kid. So kissing and telling, good, bad or indifferent, stori t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s can obviously have a dramatic impact on your bottom line. It’s a good reminder to keep your trap shut, or at least take some ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust time think about how you treat people, and especially how you discuss potentially embarrassing or harmful information with thos y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e around you. It’s not enough to leave a name out these days, as in some industries people can figure out whom you are talking . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de about pretty quickly. So unless you want to be tied up in litigation, for the next ten years, please mind your own damn busine elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Landscaping Business; Motivating Crews
|